phmacao
Enzo Maresca unmoved on Chelsea title chances but says Man City ‘will be there’How Jigawa Is Advancing Food Security, Gov Namadi’s Adviser Speaks
The college football transfer portal swung wide open Monday. With it, seven University of Massachusetts football players have put their names into the portal, looking for a new home next fall. The names that probably stick out are quarterback Ahmad Haston and running back Jalen John, both of whom went into the portal along with tight end Matt Smith, defensive linemen Tyson Walker, Zukudo Igwenagu and Aaron Beckwith, along with wide receiver Anthony Simpson. Simpson had left the team early in the season. "Portal open! Need them dogs. #Flagship" UMass quarterback A.J. Hairston wrote on X, formerly Twitter. Hairston seems to be staying put in Amherst, so it remains to be seen if his recruiting efforts will bear fruit. The now former Minutemen will leave while four incoming freshmen signed national letters of intent last week. Hitting the portal is all about recruiting, and new football head coach Joe Harasymiak broached that subject during his introductory press conference Friday morning in Amherst. "I think it starts where you are. Home is where your feet are. We'll have a detailed plan for that," he said. "I think what I realized at Maine is the first part about recruiting is you have to get people who believe in what you believe in. With everything that's going on in college football, I think that gets lost a little bit. "We're going to make sure, and we've already started in the last few days, we're going to make sure the people that are here believe in what we believe in." The biggest name that went into the portal on Monday belongs to Haston. The quarterback, recruited to UMass out of high school, became now former offensive coordinator Shane Montgomery's running quarterback in the two-quarterback plan. Haston and Hairston, a true freshman, stepped into the breach when Taisun Phommachanh was injured in the loss at Mississippi State. The two alternated in losses to Liberty and UConn at home and at Georgia. Montgomery's plan was predicated on an injury keeping Haston from really letting the ball fly. Haston finished the season by running 18 times for 174 yards and a touchdown. He averaged 9.7 yards per carry. Haston was also 8 for 9 for 39 yards. "I am truly grateful for all the memories, growth and battle-testing experiences I was able to share with my teammates," Haston posted on social media. "I am officially entering the transfer portal with 3 years of eligibility and ready to work." Jalen John, who followed former coach Don Brown from Arizona to UMass, carried the ball 111 times for 583 yards and five touchdowns in 2024. He averaged 5.3 yards per carry. John also had 17 receptions for 119 yards. "I also want to thank the UMass coaching staff and administration for giving me the opportunity to play football," John wrote on social media. "These last two years have been transformative for me as an athlete and an individual. After thoughtful conversations with my family, I will be entering the transfer portal with 1 year of eligibility left." As of this writing, redshirt junior Brandon Campbell and sophomore C.J. Hester lead the running back room. Hester transferred from Western Michigan and was the No. 2 rusher for the Minutemen. He ran the ball 119 times for 529 yards and caught 14 passes for 58 yards. Campbell, was a late arrival this summer from the University of Houston. Campbell had 239 yards rushing on 64 carries. Beckwith, a 6-foot-4, 300-pound redshirt junior had been at UMass for four seasons and had 32 tackles from the nose position in the last two seasons. Igwenagu is the cousin of former UMass fullback Emil Igwenagu, who spent three years in NFL training camps. Zukedo Igwenagu and Tyson Watson both transferred to UMass from Big Ten schools, Igwenagu from Rutgers and Watson from Michigan State. Neither had any tackle statistics in 2024. Smith is a 6-5, 245-pounder who transferred from Duke. The tight end had three catches for 38 yards. Simpson was UMass' leading receiver in 2023, catching 57 passes for 792 yards. The transfer from the University of Arizona was "no longer on the team" in a late-September announcement. Teams in the Mid-American Conference, UMass' home next year, have also felt the sting of players entering the portal. Five teams, led by Ball State with 13 and Akron and Northern Illinois with 12 each, had the most players in the portal as of midday Monday. MAC champion Ohio had yet to have a player enter the portal. There are four incoming freshmen who signed on the Dec. 4 early signing day. Two are defensive backs, one is a running back and one is a quarterback. The signal caller is Zach Lawrence, a 6-foot-1, 3-star recruit out of Charlotte, N.C. He played at Butler High School and was the No. 35 recruit in the state according to Rivals.com He had career numbers of 213 for 340 for 3,377 yards and 37 touchdowns. Dajoure Hollingsworth was listed as 247Sports' No. 19 recruit in Pennsylvania. The 5-8, 175-pound back ran for 2,565 yards on 277 carries in 32 high school games, scoring 38 touchdowns. Eighteen of those came as a senior at Salisbury School in Connecticut. He started at Cathedral Prep in Erie, Pa., the high school alma mater of former UMass linebacker Jerry Roberts Jr., and Roberts' younger brother Jyree, a redshirt freshman. "It starts off with being real, showing them who I am and how I'm going to run the program," Harasymiak said the day he was introduced. "Anybody that believes in that and wants to be a part of that will be here. That's okay. The transfer portal, you don't like it and you want to go somewhere else, that's awesome. If you want to be here and change something that's hard and be something that's going to be special. Stick around. That's my message to the team in the first two team meetings. A lot of things are going to change, a lot. That's evident that it needs to happen. "We're going to keep pushing forward and whoever is here, whoever believes in it, that's when we'll become as strong as we can be."Avior Wealth Management LLC Cuts Holdings in Emerson Electric Co. (NYSE:EMR)
Stock market today: Wall Street rallies ahead of ChristmasIsrael strikes Houthi rebels in Yemen's capital while the WHO chief says he was meters away JERUSALEM (AP) — A new round of Israeli airstrikes in Yemen have targeted the Houthi rebel-held capital of Sanaa and multiple ports. The World Health Organization’s director-general said the bombardment on Thursday took place just “meters away” as he was about to board a flight in Sanaa. He says a crew member was hurt. The strikes followed several days of Houthi attacks and launches setting off sirens in Israel. Israel's military says it attacked infrastructure used by the Houthis at the international airport in Sanaa, power stations and ports. The Israeli military later said it wasn’t aware that the WHO chief was at the location in Yemen. The US says it pushed retraction of a famine warning for north Gaza. Aid groups express concern. WASHINGTON (AP) — U.S. officials say they asked for — and got — the retraction of an independent monitor's warning of imminent famine in north Gaza. The internationally Famine Early Warning System Network issued the warning this week. The new report had warned that starvation deaths in north Gaza could reach famine levels as soon as next month. It cited what it called Israel's “near-total blockade” of food and water. The U.S. ambassador to Israel, Jacob Lew, criticized the finding as inaccurate and irresponsible. The U.S. Agency for International Development, which funds the famine-monitoring group, told the AP it had asked for and gotten the report's retraction. USAID officials tell The Associated Press that it had asked the group for greater review of discrepancies in some of the data. Trump has pressed for voting changes. GOP majorities in Congress will try to make that happen ATLANTA (AP) — Republicans in Congress plan to move quickly in their effort to overhaul the nation’s voting procedures, seeing an opportunity with control of the White House and both chambers of Congress. They want to push through long-sought changes such as voter ID and proof-of-citizenship requirements. They say the measures are needed to restore public confidence in elections. That's after an erosion of trust that Democrats note has been fueled by false claims from Donald Trump and his allies of widespread fraud in the 2020 election. Democrats say they are willing to work with the GOP but want any changes to make it easier, not harder, to vote. Americans are exhausted by political news. TV ratings and a new AP-NORC poll show they're tuning out NEW YORK (AP) — A lot of Americans, after an intense presidential election campaign, are looking for a break in political news. That's evident in cable television news ratings and a poll from The Associated Press-NORC Center for Public Affairs Research. The poll found nearly two-thirds of Americans saying they've found the need recently to cut down on their consumption of political and government news. That's particularly true among Democrats following President-elect Donald Trump's victory, although a significant number of Republicans and independents feel the same way. Cable networks MSNBC and CNN are really seeing a slump. That's also happened in years past for networks that particularly appeal to supporters of one candidate. New York to charge fossil fuel companies for damage from climate change ALBANY, N.Y. (AP) — Large fossil fuel companies would have to pay fees to help New York fight the effects of climate change under a bill signed by Democratic Gov. Kathy Hochul. The governor signed the new law Thursday. It requires companies responsible for substantial greenhouse gas emissions to pay into a state infrastructure fund for repairs or projects that help avoid future damage from climate change. Lawmakers approved the bill earlier this year. It's meant to make big oil and gas companies contribute to the cost of repairs after extreme weather events or for resiliency projects. Such projects may include restoring coastal wetlands or upgrading roads, bridges and water drainage systems. Legal challenges to the new law are expected. Aviation experts say Russia's air defense fire likely caused Azerbaijan plane crash as nation mourns Aviation experts say that Russian air defense fire was likely responsible for the Azerbaijani plane crash the day before that killed 38 people and left all 29 survivors injured. Azerbaijan is observing a nationwide day of mourning on Thursday for the victims of the crash. Azerbaijan Airlines’ Embraer 190 was en route from Azerbaijan’s capital of Baku to the Russian city of Grozny in the North Caucasus on Wednesday when it was diverted for reasons yet unclear and crashed while making an attempt to land in Aktau in Kazakhstan. Cellphone footage circulating online appeared to show the aircraft making a steep descent before smashing into the ground in a fireball. Ukraine's military intelligence says North Korean troops are suffering heavy battlefield losses KYIV, Ukraine (AP) — Ukraine's military intelligence says North Korean troops are suffering heavy losses in Russia's Kursk region and face logistical difficulties as a result of Ukrainian attacks. The intelligence agency said Thursday that Ukrainian strikes near Novoivanovka inflicted heavy casualties on North Korean units. Ukraine's president said earlier this week that 3,000 North Korean troops have been killed and wounded in the fighting in the Kursk region. It marked the first significant estimate by Ukraine of North Korean casualties several weeks after Kyiv announced that North Korea had sent 10,000 to 12,000 troops to Russia to help it in the almost 3-year war. India's former prime minister Manmohan Singh, architect of economic reforms, dies aged 92 NEW DELHI (AP) — India’s former Prime Minister Manmohan Singh, widely regarded as the architect of India’s economic reform program and a landmark nuclear deal with the United States, has died. He was 92. The hospital said Singh was admitted to New Delhi’s All India Institute of Medical Sciences late Thursday after his health deteriorated due to “sudden loss of consciousness at home." He was “being treated for age-related medical conditions,” the statement added. A mild-mannered technocrat, Singh became one of India’s longest-serving prime ministers for 10 years and earned a reputation as a man of great personal integrity. But his sterling image was tainted by allegations of corruption against his ministers. How the stock market defied expectations again this year, by the numbers NEW YORK (AP) — What a wonderful year 2024 has been for investors. U.S. stocks ripped higher and carried the S&P 500 to records as the economy kept growing and the Federal Reserve began cutting interest rates. The benchmark index posted its first back-to-back annual gains of more than 20% since 1998. The year featured many familiar winners, such as Big Tech, which got even bigger as their stock prices kept growing. But it wasn’t just Apple, Nvidia and the like. Bitcoin and gold surged and “Roaring Kitty” reappeared to briefly reignite the meme stock craze. Why this Mexican American woman played a vital role in the US sacramental peyote trade MIRANDO CITY, Texas (AP) — Amada Cardenas, a Mexican American woman who lived in the tiny border town of Mirando City in South Texas, played an important role in the history of the peyote trade. She and her husband were the first federally licensed peyote dealers who harvested and sold the sacramental plant to followers of the Native American Church in the 1930s. After her husband's death in 1967, Cardenas continued to welcome generations of Native American Church members to her home until her death in 2005, just before her 101st birthday.(BPT) - The new year is a good time to reset. From a fresh start on lifestyle choices, hobbies or pursuits, to the less exciting — but no less important — aspects of life, like memberships, contracts and even health insurance. Health insurance deductibles reset in the new year, so it's a good idea to keep that in mind as you plan for healthcare expenses. Any changes made to your health insurance plan during open enrollment go into effect as well. "Even if you spent hours researching your health plan before making a selection, there's always a possibility for the occasional surprise once coverage kicks in, which is why it's important to assess your healthcare coverage and address any gaps before January 1," said Doug Armstrong, Vice President of Health Products and Services at AARP Services, Inc. "AARP members can take advantage of benefits available to them to help find the coverage and savings information they seek." 1. Examine your vision coverage Eye health is important to quality of life, both in terms of moving around safely and appreciating your surroundings. Regular eye exams with an ophthalmologist or optometrist can help make sure your vision is sharp while also monitoring for any issues. However, many health insurance plans don't include vision coverage. If you do see a gap in your coverage, AARP members have access to information on vision insurance options that offer individual and family plans, featuring a large doctor network, savings on frames, lens enhancements, progressives and more. 2. Plan for prescriptions While several health plans offer coverage for prescription drugs, discounts can vary, especially when it comes to different types of medication. AARP ® Prescription Discounts Provided by Optum RX ® can help with savings. This program offers a free prescription discount card that can be used at over 66,000 pharmacies nationwide for savings on FDA-approved medications. Additional benefits for AARP members include home delivery, deeper discounts on medications, coverage for dependents and more. 3. Confirm your primary care With a new health insurance plan, you might find that your primary care physician is no longer in-network or that they no longer accept your insurance. Perhaps you have relocated and are in the market for a new doctor. Whatever the case, there's no time like the present to search for a new primary care physician who meets your needs. If you're on Medicare, Oak Street Health can be a great resource. The only primary care provider to carry the AARP name, Oak Street Health provides primary care for adults on Medicare and focuses on prevention with personalized care to help keep you healthy — physically, mentally and socially. Benefits include same-day/next-day appointments where available, convenient locations, a dedicated care team and a 24/7 patient support line. AARP membership is not required to visit an Oak Street Health location. 4. Protect your smile Optimal dental care includes daily brushing and flossing and a visit to the dentist every six months. During your visit, the dentist can monitor for and treat any issues, such as cavities or gum disease. However, not all plans include dental insurance, which means you might end up paying out of pocket for your cleaning and other procedures. To avoid that, take a look at your coverage. If needed, explore information on dental insurance options that offer individual or family coverage for the most common dental procedures. Dental insurance generally pays for regular check-ups, so many people who purchase protection will benefit from it immediately. 5. Clarify your hearing coverage Hearing loss is a common age-related ailment. According to the National Institute on Aging , one-third of older adults have hearing loss, and the chance of developing hearing loss increases with age. Hearing aids can be an enormous help, improving socialization, boosting confidence and even helping to increase balance. However, many insurance plans do not include coverage for hearing aids. AARP ® Hearing SolutionsTM provided by UnitedHealthcare ® Hearing provides savings on hearing aids and hearing care . Members can save an average of $2,000 per pair on prescription hearing aids and 15% on accessories — no insurance needed. Plus receive a hearing exam and consultation at no cost and personalized support through a large nationwide network of hearing providers. 6. Consider physical therapy Often, the only times that people consider whether their health insurance covers physical therapy is if they already participate in it or after the doctor has prescribed it. As we age, though, physical therapy can be a useful tool in improving balance or recovering from an injury or procedure to help you remain active. Fortunately, the question of coverage or finding an in-network location doesn't have to derail you. AARP ® Physical Therapy At HomeTM by Luna accepts most insurances and Medicare and is available to members and non-members alike. Plus, Luna's experts come to you, so you can receive quality care from the comfort of your home. If you're creating an end-of-year to-do list, consider adding an assessment of your healthcare coverage. After all, the best time to realize you have a gap in coverage is before you need it. To learn more about AARP member benefits, visit aarp.org/benefits . AARP and its affiliates are not insurers, agents, brokers or producers. AARP member benefits are provided by third parties, not by AARP or its affiliates. Providers pay a royalty fee to AARP for the use of its intellectual property. These fees are used for the general purposes of AARP. Some provider offers are subject to change and may have restrictions. Please contact the provider directly for details.
NEW YORK, Dec. 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to the Kyverna’s initial public offering conducted on February 8, 2024 (the “IPO”), of the important February 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Kyverna common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Kyverna class action, go to https://rosenlegal.com/submit-form/?case_id=32239 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 7, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, the registration statement and prospectus used to effectuate Kyverna’s IPO misstated and/or omitted facts concerning the results of Kyverna’s ongoing evaluation of KYV-101, Kyverna’s lead product candidate, in clinical trials. Specifically, Kyverna touted patient “improvement” in certain indicators while failing to disclose adverse data regarding one of Kyverna’s trials, which adverse data was known to Kyverna at the time of the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Kyverna class action, go to https://rosenlegal.com/submit-form/?case_id=32239 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com
Buy, Sell Or Hold: M&M, IOC, Asian Paints, Oil India, Varun Beverages — Ask Profit
Year in Review: North Carolina’s 24 in 2024
Robin Miller back with Vacaville Reporter
Letter: Student loan farceWhere to watch Shakhtar Donetsk vs. Bayern Munich, lineups, odds: Champions League live stream, pick
Georgia loses QB Carson Beck (arm) during SEC title gamePreserving Christmas magic with the HHFGodzilla and King Kong surely weren't born big. They began small and grew over time to their gargantuan sizes even if the movies don't tell their childhood stories. Likewise, huge companies of today were once much smaller (unless perhaps they were spin-offs). Investors who spotted them early had opportunities to make fortunes. Are You Missing The Morning Scoop? Wake up with Breakfast news in your inbox every market day. Sign Up For Free » Can you still find such monsters in the making? Three Motley Fool contributors think so. Here's why they think biotech stocks CRISPR Therapeutics (NASDAQ: CRSP) , Summit Therapeutics (NASDAQ: SMMT) , and Viking Therapeutics (NASDAQ: VKTX) could become much larger. An underrated stock with two approvals under its belt David Jagielski (CRISPR Therapeutics): If you're looking for stocks with mammoth upside, you might be tempted to look for risky stocks that don't have any approved drugs or treatments yet. But with CRISPR Therapeutics, you already have a stock that has an approved treatment -- it simply isn't far along in its rollout. In December 2023, regulators approved Casgevy, which is a gene-editing therapy the company has been developing with Vertex Pharmaceuticals . It was approved as a treatment for sickle cell disease for patients 12 years and older. Then, a month later, it was also approved to treat people with transfusion-dependent beta-thalassemia (for the same age group). Casgevy can be a game changer for patients with these rare blood disorders as it is a one-time functional cure. CRISPR will share in the profits with Vertex on Casgevy (collecting 40% of them), which could potentially help the company get to profitability. Currently, its operations are well funded with CRISPR reporting more than $1.9 billion in cash and marketable securities as of the end of September. For a business that has burned through $92.7 million in cash over the past nine months, that can provide it with a lot of runway and time to grow its operations and work on other treatments in its pipeline. At a modest market cap of just $4 billion, there's a lot of room for CRISPR to get a whole lot more valuable in the future as it scales its operations and Casgevy starts to generate revenue. Buying the healthcare stock now can be a great move for long-term investors. Already showing monster potential Keith Speights (Summit Therapeutics): It's practically unheard of for a company with no product on the market to have a market cap of $14 billion. But Summit Therapeutics is no ordinary company. The drugmaker in-licensed cancer immunotherapy ivonescimab in January 2023. That has turned out to be a brilliant move in retrospect. Earlier this year, Akeso (which originally developed ivonescimab) announced the drug beat Merck 's blockbuster immunotherapy Keytruda in a head-to-head late-stage study targeting non-small cell lung cancer (NSCLC). How big of a deal was this news? Consider that Keytruda was the world's best-selling drug last year, raking in sales of around $25 billion. Summit owns the commercial rights in the U.S., Canada, and Europe of a cancer immunotherapy that could be even more powerful than Keytruda. Granted, Summit can't ride on the clinical success achieved by Akeso. The company must conduct its own clinical studies to hopefully win approval for ivonescimab in the U.S. and elsewhere. However, that's exactly what it's doing with initial results expected from a late-stage study of the immunotherapy as a second-line treatment for NSCLC in mid-2025. Summit is also evaluating ivonescimab in another late-stage trial as a first-line treatment for NSCLC. Wall Street's consensus is that Summit's share price could soar more than 40% over the next 12 months. I'm not sure if this price target will be achieved, but it wouldn't surprise me if that's an overly pessimistic goal assuming the company announces positive clinical results next year. Summit Therapeutics is already showing monster potential. I suspect it will fulfill that potential if ivonescimab wins U.S. regulatory approval. You can still get in on the ground floor Prosper Junior Bakiny (Viking Therapeutics): Weight-loss management is the hottest therapeutic area in the pharmaceutical industry right now. Although the companies dominating the field are the usual suspects, a notable mid-cap biotech called Viking Therapeutics is looking to make waves in this market. Viking's lead anti-obesity candidate, VK2735, reported excellent results in phase 2 studies. It might still be a few years until VK2735 earns regulatory approval, but Viking Therapeutics is not a one-trick pony. The company is working on an oral version of VK2735 -- something many patients would choose over the weekly injections the original formulation comes with. Furthermore, Viking Therapeutics has another promising weight-loss candidate in preclinical studies . And I have yet to mention the drugmaker's VK2809, an investigational medicine for metabolic dysfunction-associated steatohepatitis -- a liver disease with obesity as a risk factor -- and Viking's VK0214, an investigational therapy for a rare nervous system disease called X-linked adrenoleukodystrophy. Many smaller drugmakers tend to hyperfocus on a single medicine, a strategy that allows them to avoid spreading their resources thin. Viking Therapeutics, though, is taking a different approach. The company is showing signs of one of the most critical factors successful biotechs need: innovation. There are still risks involved here. Viking's late-stage studies for VK2735 could flop. However, the company is looking increasingly attractive. In a decade, it could join the ranks of highly successful drugmakers. It's not too late to get in on the ground floor. Should you invest $1,000 in CRISPR Therapeutics right now? Before you buy stock in CRISPR Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and CRISPR Therapeutics wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $898,809 !* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. See the 10 stocks » *Stock Advisor returns as of November 18, 2024 David Jagielski has no position in any of the stocks mentioned. Keith Speights has positions in Vertex Pharmaceuticals. Prosper Junior Bakiny has positions in Vertex Pharmaceuticals. The Motley Fool has positions in and recommends CRISPR Therapeutics, Merck, Summit Therapeutics, and Vertex Pharmaceuticals. The Motley Fool has a disclosure policy . 3 Monster Stocks in the Making was originally published by The Motley Fool
KANSAS CITY, Mo. — After the Kansas City Chiefs had beaten the Raiders when Las Vegas fumbled away a chance to kick the winning field goal on the day after Thanksgiving, just about everyone wondered when the fortunes of the Super Bowl champions would take a turn for the worst. Turns out it wasn't this week, either. One of the most charmed teams in the NFL — maybe NFL history — won its 15th straight one-possession game on Sunday night when Matthew Wright, already kicking in place of two other injured kickers, banged a 31-yard field goal off the left upright and through to give Kansas City another heart-stopping, 19-17 victory over the Los Angeles Chargers. It was the Chiefs' sixth win this season decided on the final play of the game. “I'm certainly glad that we've ended up on the winning side of those games,” said Chiefs chairman Clark Hunt, who also was able to celebrate a ninth consecutive AFC West championship, the second-longest streak of division titles in history. “As we've been going through it, I've thought a lot about last year, where we had a lot of close games and they tended to go the other way, particularly in November and December,” Hunt said. "It's a credit to the level of competition in the National Football League. All these guys are professionals, they’re very talented and you know our guys have hung in there and found ways to get the ‘W’ at the end of the game.” It all begs the age-old question: Is it better to be good or lucky? Maybe the Chiefs are a little bit of both. The Chiefs (12-1) now have a two-game lead over Buffalo after the Bills lost a shootout to the Rams, and it's hard to argue they have lucked their way into the No. 1 seed in the playoff picture. But whether it was a toe-tap out of bounds against the Ravens, or three different kickers having hit game-winning field goals, the Chiefs have been operating on razor-thin margins. So perhaps the answer is the Chiefs are simply good enough that it takes a near-perfect performance to beat them. Meanwhile, a little good fortune never hurts. “Even though I feel like we could have played better, I mean that’s a good football team," Chiefs quarterback Patrick Mahomes said of the Chargers, who have now lost seven straight to their biggest nemesis in the division. “As long as we have a chance to go out there and have the football and make a play happen, I feel like we’re going to make it happen.” What’s working The Chiefs are unflappable with the game on the line, and that bodes well for the postseason, when most games are decided in the fourth quarter. In the case of Sunday night, the biggest play was a third-and-7 completion to Travis Kelce at the Chargers 20 with less than two minutes to go, which allowed Kansas City to run down the clock for the winning kick. What needs help The Chiefs have struggled with inconsistency on offense all season, and Sunday night was another example. The Chiefs managed three scoring drives in the first half, including a crisp, efficient one that ended with a touchdown throw to DeAndre Hopkins just before halftime for a 13-0 lead. But the offense was unable to produce in the second half until it needed it the most. Stock up Xavier Worthy certainly appears to have broken through the rookie wall. The first-round pick had five catches for 41 yards against the Chargers, giving him 18 catches for 202 yards and a touchdown in his past four games. Stock down The entire Kansas City pass defense, which not only struggled to pressure Chargers quarterback Justin Herbert — the two sacks by Tershawn Wharton notwithstanding — but also has had trouble in coverage for several weeks. Key number 80 — That's the number of receptions by Kelce this season. It is his NFL-record ninth consecutive year with at least that many catches, moving out of a tie with Torry Holt, Marvin Harrison and Jerry Rice for the longest streak. And the overall total number of years is tied with Tim Brown for third most in NFL history behind Rice (12) and Larry Fitzgerald (10). Next steps The Chiefs play three of their last four of the regular season on the road beginning Sunday in Cleveland. Stay Informed: Subscribe to Our Newsletter Today
CORAL GABLES, Fla. (AP) — Jim Larrañaga insists he still loves the University of Miami, still loves the game of basketball, still loves mentoring players, still loves coaching. He doesn't love what college basketball has become. And with that, he's leaving. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get updates and player profiles ahead of Friday's high school games, plus a recap Saturday with stories, photos, video Frequency: Seasonal Twice a week
Pgiam/iStock via Getty Images Investment Thesis Businesses in the correctional facilities market, otherwise known as “prison stocks” in our dusty chambers, have caught a bid in recent weeks following the outcome of the US presidential election. Whilst I am acutely aware this may be Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Stingy Devils open home-and-home with HurricanesCaitlin Clark sent a touching message to one of her teammates who is leaving Indiana Fever
